Quantitative Investment Management’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-1,864
Closed -$277K 241
2021
Q3
$277K Buy
+1,864
New +$387K 0.03% 337
2021
Q1
Sell
-15,822
Closed -$4.64M 484
2020
Q4
$4.64M Buy
15,822
+6,924
+78% +$1.78M 0.38% 51
2020
Q3
$2.1M Buy
8,898
+3,742
+73% +$851K 0.18% 106
2020
Q2
$1.02M Buy
5,156
+1,537
+42% +$287K 0.11% 204
2020
Q1
$664K Sell
3,619
-37,764
-91% -$6.72M 0.07% 274
2019
Q4
$6.91M Buy
41,383
+24,808
+150% +$3.69M 0.21% 121
2019
Q3
$2.17M Buy
+16,575
New +$2.16M 0.12% 216
2019
Q2
Sell
-2,500
Closed -$308K 612
2019
Q1
$308K Buy
+2,500
New +$314K 0.02% 559
2018
Q2
Sell
-17,200
Closed -$1.04M 717
2018
Q1
$1.04M Buy
+17,200
New +$980K 0.02% 561

Other funds holding AMED

Quantitative Investment Management's AMED Position: Q4 2021 in Review

Quantitative Investment Management sold out of Amedisys (AMED) in Q4 2021, closing a stake of 1,864 shares — an estimated $277K sold.

Quantitative Investment Management first reported a position in AMED in Q1 2018 and held it in 9 quarters. The position peaked at $6.91M in Q4 2019. 324 funds tracked by Wall St. Rank hold AMED as of Q4 2021.

  • Quantitative Investment Management reported no remaining Amedisys position as of Q4 2021 after selling out during the quarter.
  • Quantitative Investment Management sold 1,864 Amedisys shares in Q4 2021, an estimated $277K.
  • Quantitative Investment Management first reported a position in Amedisys in Q1 2018 and held it in 9 quarters.
  • Quantitative Investment Management's Amedisys position peaked at $6.91M in Q4 2019.
  • 324 funds tracked by Wall St. Rank held Amedisys as of Q4 2021.

Based on Quantitative Investment Management's 13F filing for Q4 2021, filed 14 Feb 2022.